Amid the growing digital clinical trial market, a symposium will be held in Korea where experts in life sciences such as pharmaceutical companies, CROs, university hospitals, digital healthcare companies, and healthcare investors gather in one place.
Hosted by JNPMEDI, the event will be held on November 11 at Conrad Seoul Grand Ballroom in Yeouido, Seoul, and the theme of the event is "New Paradigm of Clinical Trials: Digitalization, Patient-Centered, Hyper-connected." It is noteworthy that there will be a forum for domestic related authorities to discuss the direction of the clinical trial market, which has relied on foreign services, and to share industry trends.
In particular, the event is expected to draw more attention as JNPMEDI's clinical trial document management solution, "Maven Docs," will be unveiled. Maven Docs is a professional solution developed to maximize the efficiency of management tasks such as writing, viewing, approval, and education of clinical trial documents, and will be unveiled for the first time at this symposium event.
At this event, not only the best experts in the field of clinical trials in Korea, but also various experts who have experienced the future of clinical data management will be speakers to present actual cases and have a place of communication.
First, Byoungjun Bae, president of the Korea national enterprise for clinical trials, will take the keynote speech and open the first session, followed by a digital strategy shift of △ clinical trials, △ patient-centered daily paradigm change, and △ digital healthcare keywords VC investment sessions.
△ Juhee Cho, Professor of Samsung Medical Center, YoungJack Lee, CEO of LSK Global PS, Min Jung Lim, CEO of MediSafe, and MinSeok Kim CBO of JNPMEDI will present the change of the digital strategy session. △ Jae Yong Shin, professor of Yonsei University College of Medicine, Hanlim Moon, CEO of MediRama, Soh-Young Kim, Senior Director of IQVIA, and Jingon Kim, Director of JNPMEDI. In the △ Digital Healthcare keywords VC investment session, Chiweon Kim, M.D., Partenr of Kakao Ventures, Sejin Kim, senior associate of Murex Partners, and Gye-Hoon Park, managing director of Ajou IB investment will attend as speakers.